NRAS Q61H Protein, Human, Recombinant, Biotinylated

N-terminal AviTag™, N-terminal 6XHis

High-purity NRAS Q61H protein optimized for AlphaScreen, SPR, BLI, ELISA, pull-down, MST and oncology drug discovery applications.

Available Sizes

0.1 mg
$ 800.00

Ships with Certificate of Analysis (CoA)

Product Overview

The recombinant NRAS Q61H protein is designed for high-confidence binding and interaction studies. This construct is site-specifically biotinylated at the N-terminus for surface-based assays.

This mutation is clinically relevant and widely used in oncology and targeted therapy research.

Key Features

  • NRAS Q61H clinically relevant mutation
  • N-terminal AviTag™, N-terminal 6XHis tagged construct
  • Site-specifically biotinylated at the N-terminus
  • High purity recombinant protein
  • Optimized for binding assays
  • Research Use Only (RUO)

Applications

  • AlphaScreen
  • SPR
  • BLI
  • ELISA
  • Pull-down
  • MST
  • Protein–protein interaction studies
  • Drug discovery workflows

Biological Context & Applications

Cancer Indications

Cutaneous melanoma, Mucosal melanoma, Colorectal cancer (CRC), Acute myeloid leukemia (AML), Multiple myeloma, Papillary thyroid carcinoma, Rhabdomyosarcoma, Non-small cell lung cancer (NSCLC), Histiocytic sarcoma, Diffuse large B-cell lymphoma (DLBCL)

Binding Partners

BRAF, RAF1 (CRAF), ARAF, RALGDS, RGL2, RASSF5 (NORE1), PLCε (PLCE1), PI3K, NF1

Application Notes

Oncogenic NRAS Q61H mutant with impaired GTP hydrolysis, associated with sustained RAS signaling and activation of the RAF–MEK–ERK (MAPK) pathway. Suitable for effector binding studies, inhibitor screening, and biochemical characterization of RAS pathway interactions. Site-specific biotinylation enables oriented immobilization on streptavidin-coated surfaces for SPR, BLI, and pull-down assays.

Protein Specifications

Gene NRAS
Mutation Q61H
Organism Human
Tag N-terminal AviTag™, N-terminal 6XHis
Expression System E. coli
Purity >90% by Coomassie staining
Endotoxin <1 EU/mg
Biotinylated Yes
Oncogenic Status Oncogenic
Assay Compatibility AlphaScreen, SPR, BLI, ELISA, Pull-down, MST
UniProt ID P01111
Amino Acid Range 1-189
Buffer 20 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM MgCl2, 1 mM 2-mercaptoethanol, 10% glycerol
Storage -80 °C

Quality Control

  • Purity validated by SDS-PAGE
  • Identity confirmed by mass spectrometry
  • Assay compatibility verified
  • A Certificate of Analysis (CoA) is provided with every shipment

Ordering Information

Size Catalog No. Price Quote
0.1 mg NRAS61H-B-301-1 $ 800.00 Request Quote
Need larger quantities or custom formats? We offer bulk pricing and custom production.
Request Bulk Quote

Typical response time: 1 business day

Custom Services

Need a different format, mutation, or production scale? We offer custom RAS protein engineering tailored to your research.

Custom Mutations

Alternative NRAS variants, including rare and novel mutations.

Tag & Labeling Options

His-tag, AviTag™, biotinylation, fluorescent labeling, or tag-free formats.

Scale-Up Production

From research-scale to bulk manufacturing for screening and preclinical work.

Protein Complexes

Complex formation such as NRAS–RAF-RBD and other binding partners.

Nucleotide Loading

Pre-load NRAS proteins with defined nucleotides, including GppNHp (non-hydrolyzable GTP analog) or GDP, for consistent assay-ready performance.

Tell us your mutation, format, or assay requirements and we’ll provide a tailored quote.

Request Custom Quote Email Us

Fast turnaround • Dedicated scientific support • Confidential projects

Research Use Only. Not for diagnostic or therapeutic use.